axialHealthcare, maker of a platform for managing substance use disorder (SUD) patients, has closed $15 million in Series C funding. The raise was headlined by the Nashville company's existing investors, a list that includes Oak HC/FT, .406 Ventures, BlueCross BlueShield Venture Partners and Sandbox Advantage Fund.
WHAT THEY DO
Founded in 2012, axialHealthcare's earlier iteration focused on...